Mario Raviglione

Mario C. Raviglione has been professor at the University of Milan, Ital

http://www.unimi.it/chiedove/schedaPersonaXML.jsp?matricola=114993] since March 2018. He directs the activities focused on global health and aiming at pursuing didactic and research in this field as part of the new Multidisciplinary Research in Health Science (MACH) Centr

Part of his activities are devoted to teaching global health principles to undergraduate medical students, making the University of Milan the first in Italy, and one of the pioneers world-wide, introducing global health as a module among the required courses. At the same university, Raviglione is now coordinating the establishment of the first international online Master Course in Global Health in Ital


In 2019 and 2020, he was also Professeur Titulaire at the Global Studies Institute (GSI), Université de Genève, Suiss

Through the GSI, he has worked within the context of the Institute of Global Health

Previously, between 2003 and 2017, he was director of th
Global Tuberculosis Programme
at the World Health Organization (WHO


He graduated in medicine from the University of Turin in 1980 and then trained in internal medicine and Infectious Diseases at Cabrini Medical Center in New York City and at Beth Israel Medical Center in Boston where he was a Harvard University Clinical Fellow in Medicine and specialised in AIDS. Back in Europe, Raviglione joined WHO in 1991 as a Junior Professional Officer, and spent a few years working on TB and AIDS, TB epidemiology in Europe, and anti-TB drug resistance surveillance and response. In the mid-1990s, he set up both the WHO global drug resistance surveillance project and the WHO global TB surveillance and monitoring system

Among his major achievements are the contributions to the development of the WHO's DOTS Strategy in 1995, and the direction of the development of both the Stop TB Strategy in 200

and the End TB Strategy in 201

During his years at WHO he worked with, and visited, more than 50 countries supporting their TB care, prevention, control and research activities. His research work has resulted in over 350 scientific articles and chapters on the topics of infectious diseases, HIV/AIDS, TB, and global health, including the TB chapters in the last eight editions of Harrison's Principles of Internal Medicine. He is editor of the 3rd and 4th (2006, 2009) edition of
Tuberculosis - A comprehensive international approach
, a multi-author book, and associate editor of other books on public health, infectious diseases and tuberculosis. He directed the team that developed the book “Systematic screening for active tuberculosis – Principles and recommendations”, awarded by the British Medical Association as "Highly Commended Book" for Public Health in 2014 (https://www.bma.org.uk/-/.../about%20the%20bma/.../li-medicalbookawards-22-09-2...). He is among the top 10 most cited authors in the TB field. His h-index is 107 (Google Scholar) and 87 (Scinapse) and his work has been cited over 55000 time

He is also among the top 25 Italian epidemiological scientists and the top 100 Italian scientists in genera

As an expert in TB, he has worked as a teacher or visiting professor at Johns Hopkins University, University of Geneva, University of Modena and Reggio Emilia, and University of Pavia. He has been visiting professor at the University of Brescia

and has recently lectured at major universities including Harvard, McGill and Sydney. He participates in a variety of board of directors, scientific and advisory committees, including those of th
TB AllianceDoctors with Africa CUAMMBE Health Association
International Health Commission of the Missionary Sisters of the Sacred Heart - Cabrini Ministrie
Fondazione 3Bi
http://www.3bi.info/]. and the McGill Global Health Programs International Advisory Boar

In 2017-2018 he was member of the Lancet Commission on T

During 2015-2017 he conceived and co-organised, with WHO and the Russian Federation Ministry of Health, the first Global WHO Ministerial Conference on TB in the Sustainable Development Era, held in Moscow on 16-17 November 2017, and his team worked towards ensuring that TB is raised in the international political agenda through the United Nations General Assembly high-level meeting on TB that was held in 201

In 2005, Raviglione received th
Princess Chichibu TB Global Award
for his achievements in TB control. In 2009 he was nominated Fellow of th
Royal College of Physicians
(F.R.C.P., London, UK). In 2010, he received th
Wolfheze 20 Year Jubilee Award
for his contributions to modern TB control practices in Europe. In 2014, he was appointed a Foundation Fellow of the European Respiratory Society (F.E.R.S.). In 2014, he received the Lifetime Achievement Award by the India International Public Health Conference of the Indian Medical Association. In 2016 he was made Honorary Member of the Russian Society of Phtisiatry and in 2017 he received the USAID Global Leader Award "in recognition of innovative approach, scientific rigor, and dedicated service in partnership to End TB

In 2018 he received the "Sigillo Trecentesco" recognition from the City of Trieste for the global fight against tuberculosis and for his support to the response to an outbreak of TB among children in Trieste in 201

In November 2019 he received the title of honorary professor at the Centre for Immunobiology within the Blizard Institute, Queen Mary University of London, U.K.

References

External links

The Global TB Programme
http://www.unimi.it/chiedove/schedaPersonaXML.jsp?matricola=114993]


{{DEFAULTSORT:Raviglione, Mario
Living people

Italian pulmonologists
World Health Organization officials
University of Turin alumni
Harvard Medical School people
Year of birth missing (living people)
Italian officials of the United Nations